Open Randomized Study of Comparative Pharmacokinetics and Biosimilarity of GP40221 (GEROPHARM LLC, Russia) and Ozempic®.

Clinical trial NCT06497049 · COMPLETED

Trial details

NCT number: NCT06497049
Sponsor: Geropharm
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Safety Issues Bioequivalence

Start date: 2023-06-30
Primary completion: 2024-05-05
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.